TP53 and neuroblastoma: The study by Lakoma et al. indeed verifies the potent efficacy of RG7388, which significantly upregulates p53 transcriptional targets and p53-mediated apoptosis in p53 wild-type neuroblastoma cell lines and orthotopic xenografts.